High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human t-lymphocyte clone derived from tumor-infiltrating lymphocytes

This publication has 22 references indexed in Scilit:

• Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
  The Journal of Experimental Medicine, 1988
• Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
  The Journal of Experimental Medicine, 1988
• Role of MHC class‐i antigens and the CD3 complex in the lysis of autologous human tumours by T‐cell clones
  International Journal of Cancer, 1987
• Production of stable cytolytic T‐cell clones directed against autologous human melanoma
  International Journal of Cancer, 1987
• Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.
  The Journal of Experimental Medicine, 1986
• Functional characterization of T lymphocytes propagated from human lung carcinomas
  Clinical Immunology and Immunopathology, 1986
• Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanoma
  International Journal of Cancer, 1985
• Complexity of human T-cell antigen receptor β-chain constant- and variable-region genes
  Nature, 1984
• Allogeneic tumor rejection induced by the intravenous injection of Lyt-2+ cytolytic T lymphocyte clones.
  The Journal of Experimental Medicine, 1982
• Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans
  International Journal of Cancer, 1977